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XueShuanTong (XST) comprising therapeutically active ginsenosides, a lyophilized extract
of Panax notoginseng roots, is extensively used in traditional Chinese medicine to treat
ischemic heart and cerebrovascular diseases. Our recent study shows that treatment with
XST inhibits shear-induced thrombosis formation but the underlying mechanism remained
unclear. This study aimed to investigate the hypothesis that XST inhibited shear-induced
platelet aggregation via targeting the mechanosensitive Ca2+-permeable Piezo1 channel
by performing platelet aggregation assay, Ca2+ imaging and Western blotting analysis.
Exposure to shear at physiologically (1,000–2000 s−1) and pathologically related rates
(4,000–6,000 s−1) induced platelet aggregation that was inhibited by treatment with
GsMTx-4. Exposure to shear evoked robust Ca2+ responses in platelets that were
inhibited by treatment with GsMTx-4 and conversely enhanced by treatment with
Yoda1. Treatment with XST at a clinically relevant concentration (0.15 g L−1) potently
inhibited shear-induced Ca2+ responses and platelet aggregation, without altering vWF-
mediated platelet adhesion and rolling. Exposure to shear, while resulting in no effect on
the calpain-2 expression in platelets, induced calpain-2-mediated cleavage of talin1
protein, which is known to be critical for platelet activation. Shear-induced activation of
calpain-2 and cleavage of talin1 were attenuated by treatment with XST. Taken together,
our results suggest that XST inhibits shear-induced platelet aggregation via targeting the
Piezo1 channel to prevent Piezo1-mediated Ca2+ signaling and downstream calpain-2 and
talin1 signal pathway, thus providing novel insights into the mechanism of the therapeutic
action of XST on platelet aggregation and thrombosis formation.
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INTRODUCTION
Cardiovascular diseases (CVD) have emerged as one of the most major causes of mortality and
morbidity worldwide. It is widely accepted that platelets play a pivotal role in hemostasis and blood
clotting at the sites of vascular injuries and, furthermore, platelets represent a significant linkage
between thrombosis, inflammation and atherogenesis (Papapanagiotou et al., 2016). Hemostasis
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maintains the regulation of vascular integrity and blood flow and,
if overwhelmed, can lead to clot formation and blood vessel
occlusion. In addition to platelets, endothelial cells and
circulating coagulation proteins, blood flow is a crucial factor
in vascular hemostasis and thrombosis (Holinstat, 2017;
Koupenova et al., 2017). It is known that platelet adhesion to
immobilized von Willebrand factor (vWF) and subsequent
formation of platelet-derived micro-particles are mediated by
glycoprotein Ibα (GPIbα) under high shear stress (Kroll, 2010).
Flow-induced shear stress has significant influence on arterial
thrombus formation. In particular, increasing concentration of
platelets and/or activation of platelets at the vessel wall enhance
growth and stability of thrombi, which may result in a fatal
narrowing of the arterial lumen. The efficacy of several
antithrombotic agents is shear stress-dependent (Maxwell
et al., 2007; Sakariassen et al., 2015). Arterial thrombosis is the
major cause of myocardial infarction and stroke, while venous
thrombosis leads to venous thromboembolism and pulmonary
embolism. Structurally, arterial and venous thrombi are distinct.
Arterial thrombi are rich in platelets and form at the sides of, or
around the ruptured atherosclerotic plaques, and venous thrombi
are rich in fibrin and red blood cells (Koupenova et al., 2017).
Previous studies reported that shear-induced adhesion of platelets
at exposed sub-endothelial collagen/vWF allows platelets to
aggregate (Maxwell et al., 2007; Cosemans et al., 2013). A
recent study has reported that the PI3K-C2α lipid kinase
mediates shear-dependent regulation of platelet adhesive
function via altering the internal membrane structures
(Mountford et al., 2015). Piezo1 was first showed to form a
mechanosensitive or mechanically activated Ca2+-permeable
cation channel in mouse neuroblastomas cell (Coste et al.,
2010). The Piezo1 channel opens by shear-induced bilayer
tension (Lewis and Grandl, 2015; Cox et al., 2016; Syeda et al.,
2016) and changes in membrane curvature (Guo and
MacKinnon, 2017; Lin et al., 2019) and mediates Ca2+ influx
and activation of downstream signal pathways (Li et al., 2014;
Ranade et al., 2014). Numerous studies have now confirmed that
the Piezo1 channel senses diverse mechanical stimuli and
regulates a wide range of cell functions and biological
processes (Li et al., 2014; Cahalan et al., 2015; Hyman et al.,
2017; Wu et al., 2017; Romac et al., 2018; Zhong et al., 2018). A
recent study suggests that the Piezo1 channel plays a role in
mediating Ca2+ entry into platelets and thrombus formation
under arterial shear stress (Ilkan et al., 2017).
Currently available antithrombotic drugs, including the widely
used antiplatelet agents and anticoagulants, are associated with
significant bleeding risk. There is growing awareness of the use of
herbs in the prevention of platelet aggregation and treatment of
related CVDs. Panax notoginseng (Burk.) F. H. Chen, an
important herb used in traditional Chinese medicine (TCM),
has been reported to have beneficial effects, including promotion
of blood circulation, removal of blood stasis, relief of pain and
hemostasis. It has been extensively used since it was discovered in
the Ming dynasty and its medical functions were described in the
Compendium of Materia Medica (Ben Cao Gang Mu). The most
important and active ingredients of panax notoginseng are
saponins in a variety of monomeric species, including
ginsenosides (Rg1, Rb1, Re, Rd, Rb2, Rb3, Rc) and
notoginsenosides (R1, R2, R3 and R6). Studies have shown that
Panax notoginseng saponins (PNS) have the effects of anti-
myocardial infarction (Liu et al., 2014), antithrombotic (Lau
et al., 2009; Liu et al., 2018), anti-inflammatory (Chang et al.,
2007), antioxidant (Peiran et al., 2017) and amelioration of
microcirculation disorders (Han et al., 2017). An early study
reported that PNS had an inhibitory effect on shear-induced
platelet aggregation (Liao, 1997), but the underlying mechanism
of action remains unclear. Xueshuantong used in TCM for the
prevention and treatment of thrombosis contain high content of
PNS. Our recent studies show that XST inhibited platelet
activation and adhesion to injured endothelial cells (ECs)
in vitro (Han et al., 2019) and also inhibited tail thrombosis
formation induced by κ-carrageenan in rats and ameliorated
vascular hemodynamic status (Liu et al., 2020). Interestingly,
such an inhibitory effect of XST was shear-dependent but the
underlying mechanism remained unclear. In the present study,
we provide evidence to support that XST inhibits shear-induced
platelet aggregation via the mechanosensitive Piezo1 channel.
MATERIALS AND METHODS
Reagents
XueShuanTong, with the Chinese NMPA drug ratification
number of GuoYaoZhunZi-Z20025652, has been manufactured
as a sterile and nonpyrogenic lyophilized solid for intravenous
administration. Each gram of XST was prepared from 15.4 g of
Sanqi (P. notoginseng (Burk.) F. H. Chen). XST used in this study
was obtained from Guangxi Wuzhou Pharmaceutical Group with
lot No.17081507 (Wuzhou, Guangxi Zhuang Autonomous
Region, China).
Yoda1 (448947-81-7) and GsMTx-4 peptide (STG-100) were
purchased from Tocris Bioscience (Bristol, United Kingdom) and
Alomone Labs (Jerusalem, Israel), respectively. XST was dissolved
in saline at 30 mg mL−1 storage concentration; Yoda1 in DMSO
at 10 mM storage concentration; GsMTx-4 in water at 100 μM
storage concentration. Storage concentration of XST, GsMTx-4
and Yoda1 was diluted by saline when tested. Yoda1 was diluted
to the final concentration of 25 μM (0.25% v/v DMSO). Previous
studies revealed that 0.25% (v/v) DMSO showed neither obvious
influences on ADP, collagen or thrombin induced platelets
aggregation (Yi et al., 2017; Wang et al., 2019) nor shear-
induced platelet aggregation (Supplementary Figure S1).
Calcein-AM and Fluo3-AM were from Invitrogen (Carlsbad,
CA, United States) and Dojindo Laboratories (Kumamoto,
Japan), respectively. Type I collagen (#385) was from Chron-
Log Corp (Havertown, PA, United States), and von Willebrand
Factor (Z0409) was from Hematologic Technologies (Essex
Junction, VT, United States). Anti-Piezo1 antibody (APC-087)
was from Alomone Labs, and anti-calpain2 antibody (Cat No.
11472-1-AP), anti-talin1 antibody (Cat No. 14168-1-AP), anti-
vinculin antibody (Cat No. 66305-1-Ig), anti-β-actin (Cat No.
66009-1-Ig), horseradish peroxidase (HRP)-conjugated
Affinipure goat anti-mouse IgG antibody (SA00001-1) and
HRP-conjugated Affinipure goat anti-rabbit IgG antibody
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(SA00001-2) were from ProteinTech (Rosemont, IL,
United States).
Platelet Preparation
The procedures of blood withdrawal frommale Sprague-Dawley
rats (250 ∼ 270 g) were performed in accordance with the
guidelines approved by the Animal Care and Use Committee
of Institute of Chinese Materia Medica, China Academy of
Chinese Medical Sciences (Beijing, China). Rats were
obtained from the Experimental Animal Center, Charles
River Laboratories (Beijing, China) [SCXK2016-0006], and
housed at 15–28°C and humidity of 45–55%, with free access
to food and drink, for 3 days before used. Rats were anesthetized
by injection of 60 mg kg−1 sodium pentobarbital at a
concentration of 3%, and 8 ml of whole blood samples were
withdrawn from the abdominal aorta per rat and anticoagulated
using 109 mM sodium citrate (1:9). For platelet aggregation
assay, platelet-rich plasma (PRP) was obtained by centrifugation
of the blood sample at 200 × g for 10 min. For Ca2+ imaging and
Western blotting, platelets were prepared as follows: PRP was
mixed with ACD (2.5% trisodium citrate, 2.0% glucose, and
1.5% citric acid) and EDTA (100 mM) in a ratio of 9:1:0.2, and
centrifuged at 400 × g for 10 min. Platelets were suspended with
Tyrode’s solution (138 mM NaCl, 3.3 mM NaH2PO4, 2.9 mM
KCl, 1 mMMgCl2, 5.5 mM glucose, and 20 mMHEPES, pH 7.2)
and were centrifuged again at 400 × g for 10 min. Platelets were
re-suspended in Tyrode’s solution. Preparation of platelets was
conducted at room temperature.
Platelet Aggregation Assay
The High Shear BioFlux 48-well plates (Fluxion Biosciences,
Alameda, CA, United States) were used. The microfluidic
channels were coated with 40 μg m L−1 collagen for 1 h, and
then blocked with 0.5% bovine serum albumin (BSA) in
phosphate-buffered saline (PBS) at room temperature. The
platelet density in PRP was adjusted to 5.0 × 1010/L with
Tyrode’s solution, and the platelet suspension was incubated
with Calcein-AM (5 µM) for 1 h at room temperature in dark.
Calcein-AM-labelled platelets were treated with XST (0.15 g L−1
or 0.6 g L−1), GsMTx-4 (2.5 µM), Yoda1 (25 µM), Yoda1 (25 µM)
plus XST (0.15 g L−1 or 0.6 g L−1), or vehicle (saline) for 10 min at
37°C in dark.
Platelets were perfused to the microfluidic channels with
incremental pressures of 0.13, 0.33, 0.66, 1.32, 2.64 psi for 5 min,
which resulted in wall shear rates of 400, 1,000, 2,000, 4,000, and
8,000 s−1, respectively, and the whole shear flow continued for
25 min. Fluorescent micrographs of adhesion and aggregation
of platelets were captured by a time-lapse inverted microscope
(wavelength FITC module; exposure time: 400 ms) using an
Axio Observer 7 (Carl Zeiss AG, Oberkochen, Germany) and a
C11440-42U30 digital camera (Hamamatsu Photonics,
Shizuoka, Japan). The BioFlux-1000Z system (Fluxion
Biosciences, Alameda, CA, United States; Conant et al., 2011)
was utilized to control the shear rate and image acquisition
settings. Platelet aggregation rates were determined by the
fluorescence intensity using bio flux Montage software
(Fluxion Biosciences, Alameda, CA, United States). Three
independent experiments were carried out with at least
triplicate.
Platelet Adhesion and Rolling Assays
The High Shear BioFlux 48-well plates were utilized. The
microfluidic channels were coated with 70 μg m L−1 vWF for
1 h and then blocked with 0.5% (v/v) BSA in PBS for 10 min at
room temperature. The sodium citrate anti-coagulated whole
blood was treated with XST (0.15 g L−1 or 0.6 g L−1) or vehicle
(saline) for 10 min at 37°C prior to perfusion at a shear rate of
750 s−1 (shear stress of 3 Pa) for 10 min. Subsequently, the
channels were washed for 5 min at a shear rate of 1,000 s−1
with HBSS (with calcium and magnesium) until all red and
white blood cells were clear of the channels. Only platelets
were loaded on the surface of channels coating with vWF
protein. The rolling of platelets under a shear rate of 6,000 s−1
with HBSS containing saline or XST (0.15 g L−1 or 0.6 g L−1) was
recorded by time-lapse imaging every second for 30 s. The platelet
adhesion and rolling speed were measured using bio flux
Montage software (Fluxion Biosciences, Alameda, CA, United
states). Measurements of distance/time were taken for 10 rolling
platelets in each field. Three independent experiments were
carried out same as described above.
Ca2+ Imaging in Platelets
The effects of XST on shear-induced Ca2+ influx were assessed
using bio flux 24-well plates with a two-inlet well (A and B) to
one-outlet well (O) per channel design (Supplementary Figure
S2). The 24-well microfluidic channels were coated with
40 μg mL−1 collagen for 1 h and then blocked with 0.5% BSA
in PBS for 10 min at room temperature. Platelets were adjusted
to a density of 3 × 108/ml with Tyrode’s solution containing
1 mM CaCl2 and incubated with 5 µM Fluo3-AM for 45 min at
37°C in dark. All inlet A wells were filled with Fluo3-AM-labeled
platelets and inlet B wells were added with 1 ml of XST
(0.15 g L−1), GsMTx-4 (2.5 µM), Yoda1 (25 µM), or Yoda1
(25 µM) together with XST or saline. Flow was initiated from
the inlet A wells at a shear rate of 200 s−1 (shear stress of 0.2 Pa)
for 2 min to load platelets on the surface of channels,
accompanied with sequential perfusion from the inlet B wells
starting automatically and continuing for 10 min at a shear rate
of 1,000 s−1 (shear stress of 1 Pa). Fluorescent images were
captured every 30 s for 12 min. Fluorescent intensity was
determined by bio flux Montage software (Fluxion
Biosciences, Alameda, CA, United States). The fluorescent
intensity (F) was corrected for background before normalized
to the initial fluorescence intensity (F0) to yield the F/F0 values.
Three independent experiments were carried out same as
described above.
Western Blotting
For shear conditions, platelets were incubated with saline, XST
(0.15 g L−1 or 0.6 g L−1), GsMTx-4 (2.5 µM), Yoda1 (25 µM), or
Yoda1 (25 µM) plus XST for 10 min before added into BioFlux
48-well plates and subjected to shear at a rate of 4,000 s−1 for
30 min. For static conditions, platelets were incubated with same
volume of saline and subjected to no flow for 30 min. Platelets
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were collected by centrifugation for 10 min at 1,200 × g and lyzed
in radio-immune precipitation assay buffer containing 1 mM
phenylmethylsulfonyl fluoride. After centrifugation at
13,000 × g and 4°C for 5 min, the protein concentrations in
the supernatants were measured using a bicinchoninic acid assay
kit (Thermo Fisher Scientific, MA, United States) according to the
manufacturer’s instructions. Proteins of 30–40 µg were separated
by electrophoresis on 10% sodium dodecyl sulfate-
polyacrylamide gels, and subsequently transferred onto
polyvinylidene difluoride membranes. Membranes were
blocked with 5% skim milk in Tris-buffered saline containing
Tween 20 (TBST) (20 mM Tris-HCl, pH 7.5, 137 mM, NaCl, and
0.1% Tween 20) at room temperature for 2 h, and incubated with
primary anti-Piezo1 (1:600), anti-Calpain-2 (1:2,000), anti-talin1
(1:500), anti-vinculin (1:5,000), anti-β-actin (1:5,000), or anti-
GAPDH antibody (1:5,000) at 4°C overnight. After washing with
TBST, the membranes were incubated with HRP-conjugated
secondary antibodies for 2 h at room temperature. Proteins
were visualized by enhanced chemiluminescence (ECL)
(Millipore, MA, United States) and imaged using an ECL
detection system (Syngene, Cambridge, United Kingdom). The
protein density was analyzed by ImageJ software. Three
independent experiments were carried out same as
described above.
Statistical Analysis
All the platelet aggregation rates data were expressed as mean ±
SD, and two-way analysis of variance (ANOVA) followed by
post-hoc Tukey’ test was performed; the other data were
expressed as mean ± SEM, and one-way ANOVA followed by
post-hoc Tukey’ test was performed using SPSS 20.0 software
(IBM, Armonk, NY, United States). At least three independent
experiments were carried out. p < 0.05 was considered statistically
significant.
RESULTS
Chemical Quality Control of XueShuanTong
Each gram of XST was prepared from 15.4 g of Sanqi (Panax
notoginseng (Burk.) F. H. Chen). XST used in this study was
obtained from Guangxi Wuzhou Pharmaceutical Group with lot
No. 17081507 (Wuzhou, Guangxi Zhuang Autonomous Region,
China). XST contain five major saponins ginsenoside Rg1 (43.5%),
ginsenoside Rb1 (27.8%), notoginsenoside R1 (12.6%), ginsenoside Re
(5.6%) and ginsenoside Rd (2.3%), and these five major ginsenosides
make up 91.8%. The chemical structures of these five ginsenosides in
XST are shown in Figure 1 and the chemical analysis data of XST is
provide by the company shown in Supplementary Figure S3. An
FIGURE 1 | The five major ginsenosides in XueShuanTong and their chemical structures. (A) Notoginsenoside R1 (12.6%). (B) Ginsenoside Rg1 (43.5%). (C)
Ginsenoside Re (5.6%). (D) ginsenoside Rb1 (27.8%). (E) ginsenoside Rd (2.3%).
Frontiers in Pharmacology | www.frontiersin.org March 2021 | Volume 12 | Article 6062454
Liu et al. XST Inhibits Shear-Induced Platelet Aggregation
offline 2D LC/QTOF-Fast DDA approach was developed with the
view of systematic exposure and characterization of the minor
saponins contained in XST. As many as 143 minor saponins were
separated and characterized (Yang et al., 2016), the content of trace
components is almost clear till now andmake up range of 9 ∼ 12% in
XST in the quality control report.
Shear Induces Platelet Aggregation via
Activating the Piezo1 Channel
A recent study has reported the expression of the Piezo1 channel in
platelets as a mechanosensitive ion channel that can be activated by
shear (Ilkan et al., 2017). We were interested in whether shear
enhanced platelet aggregation and, if it did, whether such an effect
occurred via activating the Piezo1 channel. Subendothelial collagen
exposure is a thrombogenic factor inducing platelet aggregation in
vivo. We assessed the effect of shear on collagen-induced platelet
aggregation by applying shear to platelets on collagen-coated surface,
starting at a shear rate of 400 s−1 and increasing to 1,000 and 2,000 s−1
observed under physiological conditions, and further to 4,000 and
8,000 s−1 under pathological conditions. As shown in Figures 2A,B,
exposure to shear resulted in a significant and shear rate dependent
increase in platelet aggregation. There were interactions between
shear rate and treatment with GsMTx-4 or Yoda1 on platelet
aggregation (F  2.343, p  0.029) by two-way ANOVA, which
implied that GsMTx-4 or Yoda1 influenced shear induced platelet
aggregation. Treatment of platelets with 2.5 µM GsMTx-4, a peptide
known to inhibit the Piezo1 channel (Bae et al., 2011; Hara et al.,
2012; Pathak et al., 2014), attenuated shear induced platelet
aggregation at shear rate of ≥2000 s−1 (Figure 2C), and compared
with vehicle, GsMTx-4 reduced platelet aggregation significantly (p <
0.05 or p < 0.01). Conversely, treatment with 25 µM Yoda1, a Piezo1
channel agonist, enhanced shear-induced platelet aggregation at
shear rate of 8,000 s−1(p  0.018), though such a stimulatory
effect was not statistically significant at shear rate ranged from
400 to 4,000 s−1 (Figures 2B,C).
XueShuanTong Inhibits Shear-Induced
Platelets Aggregation
We next investigated whether treatment with XST affected
shear-induced platelet aggregation. There were interactions
FIGURE 2 | Role of the Piezo1 channel in shear-induced platelet aggregation. (A) Representative images showing effects of treatment with GsMTx-4 (2.5 µM) and
Yoda1 (25 µM) on platelet aggregation under shear rates of 400, 1,000, 2,000, 4,000 and 8,000 s−1. The scale bar is 50 µm. (B)Mean time-course of plate aggregation
from three independent experiments under the conditions shown in (A). (C)Mean platelet aggregation rate at the end of exposure to indicated shear rates. *p < 0.05 and
**p < 0.01, analyzed by two-way ANOVA and post-hoc Tukey’s test.
Frontiers in Pharmacology | www.frontiersin.org March 2021 | Volume 12 | Article 6062455
Liu et al. XST Inhibits Shear-Induced Platelet Aggregation
between shear rate and treatment with XST or GsMTx-4 on
platelet aggregation by two-way ANOVA (F  2.306, p 
0.024), which indicated that XST or GsMTx-4 affected shear
induced platelet aggregation. Treatment with XST at a
concentration of 0.15 g L−1 (XST-L), prior to and during
exposure to shear, strongly reduced platelet aggregation
induced by shear at a rate exceeding to 2000 s−1. Treatment
with XST at a relatively high concentration of 0.6 g L−1 (XST-
H) resulted in similar inhibition of shear-induced platelet
aggregation (Figure 3A; Supplementary Videos S1A–D).
Figure 3B shows the mean platelet aggregations rate at the
end of exposure to shear with the rates of 400, 1,000, 2,000,
4,000 and 8,000 s−1 under indicated conditions (vehicle,
GsMTx-4, XST-L and XST-H). Under the shear rate level
higher than 2,000 s−1, multiple comparison by post-hoc
Tukey’ test showed that compared to the vehicle group,
treatment with GsMTx-4, XST-L or XST-H significantly
inhibited platelet aggregation induced by physiological
2,000 s−1 or pathophysiological shear (4,000–8,000 s−1)
(Figure 3B) (p < 0.05 or p < 0.01).
We performedWestern blotting to examine the Piezo1 protein
level in platelets under static and shear conditions and also
platelets treated with GsMTx-4, XST-L and XST-H under
shear. Compared with static conditions, the Piezo1 protein
level was significantly enhanced after exposure to shear (1,000,
4,000 or 10,000 s−1), which may contribute to shear-induced
platelet aggregation. Treatment with GsMTx-4, XST-L or XST-
H showed no effects on the Piezo1 protein expression under high
shear rate (Figure 3C), suggesting that XST inhibits shear-
induced platelet aggregation mainly via preventing activation
of the Piezo1 channel. In order to interpret the piezo1 channel
function in shear-induced platelet aggregation step by step, we
grouped the Western blotting data in both Figures 3C, 4C which
were highlighted by black lines and the original images are
supplemented. Aspirin has neither effects on shear-induced
platelets aggregation nor on piezo1 expression, and the results
of aspirin were shown as the Supplementary Figure S4.
We also examined the effects of treatment with XST-L or XST-
H on shear-induced platelet aggregation in the presence of Yoda1,
as shown in Figure 4A and Supplementary Videos S1E–G.
Figure 4B shows the mean platelet aggregations rate at the
end of exposure to indicated shear rates under these
conditions. There were very significant interactions between
shear stress and treatment with Yoda1 or Yoda1 together with
XST on platelet aggregation by two-way ANOVA (F  10.32, p <
0.001), which suggested that Yoda1 together with XST affected
shear induced platelet aggregation. At shear rate of 400, 1,000,
2,000, 4,000 and 8,000 s−1, multiple comparison by post-hoc
FIGURE 3 | Effects of treatment with XST on shear-induced platelet aggregation. (A) Representative images showing effects of treatment with XST at 0.15 g L−1
(XSTL) or 0.6 g L−1 (XSTH) and GsMTx-4 (2.5 µM) on platelet aggregation. The scale bar 50 µm. (B)Mean platelet aggregation rate at the end of exposure to indicated
shear rates under the conditions shown in (A). *p < 0.05 and **p < 0.01, analyzed by two-way ANOVA and post-hoc Tukey’s test. (C) Western blotting analysis of the
Piezo1 expression in platelets under static conditions or after exposure to indicated shear alone or together with GsMTx-4 or XST, and the grouping and splicing
was highlighted by black lines. Top: representative blots; bottom: mean data from three independent experiments by one-way ANOVA. *p < 0.05 compared to platelets
under static conditions.
Frontiers in Pharmacology | www.frontiersin.org March 2021 | Volume 12 | Article 6062456
Liu et al. XST Inhibits Shear-Induced Platelet Aggregation
Tukey’ test shows that treatment with XST-L and XST-H
significantly inhibited platelet aggregation induced by shear
and Yoda1 (p < 0.05 or 0.01). We also examined using
Western blotting the Piezo1 protein level in platelets exposed
to shear at a rate of 4000 s−1, in the presence of Yoda1 or Yoda1
together with XST. Exposure to Yoda1 alone, or Yoda1 together
with XST resulted in no significant effect on the Piezo1 expression
(Figure 4C). These results provide further evidence to support
that XST inhibits shear-induced platelet aggregation mainly via
the Piezo1 channel function.
Interactions between platelets and vWF play an important role
in shear-induced platelet aggregation under high shear rates
(>5,000 s−1) and, in addition, the arrest of flowing platelets
(adhesion and rolling) on vWF surface are thought to be
mediated by the interactions between the A1 domain of vWF
and the platelet receptor GPIbα (Ruggeri et al., 2006). We were
interested in whether XST can affect shear-induced platelet
aggregation through altering the interactions of platelets with
vWF. To address, platelet adhesion and rolling on vWF-coated
surface under high shear rate of 6,000 s−1 was assessed. Platelets
adhered to vWF-coated surface as small aggregates, which were
different from thrombi formed on collagen-coated surface.
Neither platelet adhesion nor rolling was significantly altered
by treatment with XST (Supplementary Figure S5). Taken
together, our results suggest that XST preferentially inhibits
shear-induced platelet aggregation with minimal effect on
vWF mediated platelet adhesion and rolling.
XueShuanTong Inhibits Shear-Induced
Piezo1-Mediated Ca2+ Signaling in Platelets
To provide direct evidence to support the notion that XST
inhibits shear-induced platelet aggregation via targeting the
Piezo1 channel, we next examined the effect of treatment with
XST on shear-induced Ca2+ responses in platelets, using Ca2+
fluorescent indicator Fluo3-AM. The single platelet fluorescent
intensity (F) was corrected for background before normalized to
the initial fluorescence intensity (F0) to yield the F/F0 values, three
independent experiments were carried with totally 20 platelets
during 12 min (Figure 5A). Figure 5B shows the multiple
FIGURE 4 | Effects of XST on platelet aggregation induced by shear stress and Yoda1. (A) Representative images showing the effects of treatment with Yoda1
(25 µM) alone or together with XST at 0.15 g L−1 (XSTL) or 0.6 g L−1 (XSTH) on shear-induced platelet aggregation. The scale bar 50 µm. (B)Mean platelet aggregation
rate at the end of exposure to indicated shear rates. #p < 0.05 and ##p < 0.01, analyzed by two-way ANOVA and post-hoc Tukey’s test. (C)Western blotting analysis of
the Piezo1 expression in platelets under shear rate of 4,000 s−1 and exposure to Yoda1 (25 μM) alone or Yoda one together with XST, and the grouping was
highlighted by black lines. Although shear induced platelets aggregation was enhanced by Yoda1, however, exposure to Yoda1 alone, or Yoda1 together with XST
resulted in no significant effect on the Piezo1 expression. Top: representative blots; bottom: mean data from three independent experiments.
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comparison with F/F0 distribution plot of 20 platelets in each
group at the time of 8.5 min. F value from ANOVA analysis
among these five groups is 19.547, p < 0.001. Exposure of platelets
to shear at a rate of 1,000 s−1 induced a robust Ca2+ increase in
platelets, and such Ca2+ response was enhanced by treatment with
Yoda1 (p  0.03) and, conversely, was strongly suppressed by
treatment with GsMTx-4 (p < 0.01) These results are highly
consistent with the notion that shear-induced activation of the
Piezo1 channel results in an increase in the Ca2+ concentration in
platelets as reported by a recent study (Ilkan et al., 2017).
Similarly, shear-induced Ca2+ response was strongly
suppressed by treatment with XST (0.15 g L−1). Such treatment
with XST also significantly reduced Ca2+ responses induced by
shear and Yoda1. These results provide evidence to show that
XST inhibits shear-induced activation of the Piezo1 channel and
thereby shear-induced Ca2+ signaling in platelets.
Effects of XueShuanTong on Platelet
Aggregation Related Proteins Expressions
Under High-Shear Stress
A recent study has shown calpain activation downstream of
shear-induced Piezo1-mediated Ca2+ signaling in endothelial
cells (Li et al., 2014). Several Ca2+ responsive proteins have
been identified that control this inside-out integrin activation.
Activation of Ca2+ dependent protease calpain and cleavage of its
target talin was demonstrated after Piezo1 activation in epithelial
cells (McHugh et al., 2010). Calpain catalyzing activity was
significantly increased upon Yoda1 treatment (Aglialoro et al.,
2020) and calpain cleaves talin to an activated state mediating
inside-out integrin activation (Goksoy et al., 2008; McHugh et al.,
2010). We therefore performed western blotting to examine
whether treatment with XST altered the expression of calpain-
2 and vinculin, the downstream signals of Piezo1, which are
known to be involved in platelet activation and aggregation
(Serrano and Devine, 2004; Kuchay and Chishti, 2007).
Neither calpain-2 nor vinculin protein level in platelets was
altered by treatment with shear, Yoda1 or GsMTx-4.
Treatment with XST resulted in no significant alteration in the
expression of calpain-2 and vinculin (Figure 6A). Calpain-2
catalyzes cleavage talin1 protein from its 230 kDa isoform to a
smaller 190 kDa isoform, which is recruited to form a complex
with the GPIIIbIIIa protein to induce activation of platelets.
Western blotting analysis indicated that cleavage of talin1 in
platelets under shear with a rat of 4,000 s−1 was inhibited by
treatment with MDL28170, a calpain-2 inhibitor
(Supplementary Figure S6), suggesting shear-induced
activation of calpain-2 in platelets. In platelets under such
shear condition, treatment with Yoda1 enhanced a reduction
of the 230 kDa protein level and a simultaneous increase in the
190 kDa protein level, while treatment with GsMTx-4 had no
effect (Figure 6B). These results implied that synergic
stimulation of the Piezo1 channel activity by shear and
Yoda1 led to activation of Calpain-2 and subsequent
cleavage of talin1 (Figure 6B). Treatment together with
XST significantly attenuated the reduction in the 230 kDa
protein level or the increase in the 190 kDa protein level,
suggesting XST inhibits shear/Yoda1-induced activation of
calpain-2 and subsequent cleavage of talin1 (Figure 6B).
These results are consistent with that XST inhibits shear-
induced platelet aggregation via Piezo1-mediated Ca2+
signaling and subsequent calpain-2 activation and talin1
cleavage as downstream signal pathways (Figure 7).
DISCUSSION
The aim of this study is to explore the effects and mechanism of
XST on shear-induced platelet aggregation. Microfluidic system
was used to generate controlled shear stress on platelet
aggregation. Numerous recent studies have revealed an
important role of the Ca2+-permeable Piezo1 channel in
sensing mechanical forces and regulating a bewildering
number of physiological processes including vascular
FIGURE 5 | Effects of treatment with XST on shear induced Ca2+ responses. (A) Time-course of changes in intracellular Ca2+ mean levels (F/F0) in platelets
subjected to a shear rate of 1,000 s−1 without (vehicle) and with treatment with GsMTx-4 (2.5 µM), Yoda1 (25 µM), XST (0.15 g L−1), and XST together with Yoda1. (B)
Effects of treatment with GsMTx-4, Yoda1, XST or XST together with Yoda1 on shear-induced Ca2+ responses in platelets at time point of 8.5 min. Three independent
experiments were undertaken. *p < 0.05 and **p < 0.01 compared to the vehicle group; #p < 0.05 compared to platelets treated with Yoda1 alone, analyzed by one-
way ANOVA and post-hoc Tukey’s test.
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development, vascular tone and blood flow (e.g., Li et al., 2014;
Wang et al., 2016; Beech, 2018). Mechanical activation of the
Piezo1 channel is essential for homeostasis of red blood cell
(Cahalan et al., 2015). It has been shown in a recent study that
Piezo1 functions as a mechanosensitive channel in human
platelets that mediates arterial shear-induced Ca2+ entry and
thrombus formation (Ilkan et al., 2017). Shear stress activates
Piezo1 (Douguet et al., 2019), and the opening of endothelial
Piezo1 channels by shear stress activates downstream Ca2+-
dependent calpains, which in turn are responsible for focal
adhesion turnover, proteolytic cleavage of actin cytoskeletal
elements, and alignment of ECs to blood flow (Beech, 2018).
In this study, we showed an increase in the Ca2+ level in platelets
in response to a wide range of physiologically and pathologically
relevant shear (Figure 5). Such Ca2+ responses were inhibited by
treatment with GsMTx-4 to inhibit the Piezo1 channel or further
enhanced by treatment with Yoda1 (Figure 5). Interestingly,
western blotting analysis also revealed that exposure to high
shear significantly unregulated the expression of the Piezo1
channel (Figure 3C). Such shear-induced regulation of the
Piezo1 channel expression was insensitive to treatment with
GsMTx-4, suggesting engagement of a Piezo1-independent
mechanism which requires further investigation. Overall, our
results indicate that shear induces activation of the Piezo1
channel leading to Ca2+ influx in platelets. In the present
study we also showed that exposure to physiological and
pathological shear stimulated platelet aggregation that was
strongly suppressed by treatment with GsMTx-4 (Figure 2),
an inhibitor of Piezo1 channel, providing evidence to suggest
that shear-induced platelet aggregation via activating the Piezo1
channel.
Piezo1 channels may directly function as shear stress sensors
involved in perceiving shear stress and critical for calcium influx
and subsequent integrin activation. In endothelial cells, Piezo1
activation has been associated with integrin activation and
increased cell adhesion resulting in integrin-dependent focal
adhesion kinase signaling under flow shear stress. Reduced
integrin activation was observed in an endothelium-specific
Piezo1 deficient mouse model (Albarrán-Juárez et al., 2018).
In agreement with this, depletion of Piezo1 in small lung
cancer cell lines also caused decreased integrin activation
(McHugh et al., 2012). Activation of Piezo1 on erythroblasts
by Yoda1 causes activation of downstream Ca2+ mediators
calpain and PKC, resulting in inside-out activation of integrins
(Aglialoro et al., 2020). Also several Ca2+ responsive proteins have
been identified that control this inside-out integrin activation, for
instance, the Ca2+ dependent calpain unmasks the β-integrin
binding motif of talins leading to integrin activation (Goksoy
et al., 2008; McHugh et al., 2010). It is well known that the Ca2+
signaling plays an important role in platelet activation and
aggregation. Studies have reported that shear-induced Piezo1-
mediated Ca2+ signal activates calpain-2 (Miyazaki et al., 2010; Li
et al., 2014). Calpain-2 is a calcium-dependent protease,
meanwhile calcium influx activates calpain-2. Talin-1, one of
calpain-2 substrates, is a large (∼2,540 residues) dimeric adaptor
protein that associates with the integrin family of cell adhesion
molecules in cell-extracellular matrix junctions, where it both
activates integrin and couples them to the actin cytoskeleton.
FIGURE 6 | Effects of XST on the expression of platelet aggregation-related proteins under shear stress. (A)Western blotting analysis of the expression of calpain-2
and vinculin in platelets subjected to shear at a rate of 4,000 s−1 and treated with saline, GsMTx-4 (2.5 µM), Yoda1 (25 µM) and XST at 0.15 g L−1 (XSTL) or 0.6 g L−1
(XSTH). Treatment with XST resulted in no significant alteration in the expression of calpain-2 and vinculin. (B) Western blotting analysis of talin1 cleavage in platelets
subjected to shear at a rate of 4,000 s−1 and treated with saline, GsMTx-4 (2.5 µM), Yoda1 (25 µM), and Yoda1 together with XST at 0.15 g L−1 or 0.6 g L−1
highlighted by black lines. Top: representative blots; bottom: mean data from three independent experiments. *p < 0.05, **p < 0.01 compared to platelets subjected to
shear alone; #p < 0.05, ##p < 0.01 compared to platelets treated with Yoda1 alone highlighted by black lines.
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Calpain cleaves talin to an activated state mediating inside-out
integrin activation (Goksoy et al., 2008; McHugh et al., 2010).
Calpain-2 has been implicated in the modulation of integrin
signaling, particularly the αIIbβ3 (GPIIb/IIIa) integrin-mediated
signaling during platelet activation. Calpain-2 regulates adhesion
turnover and disassembly of platelets through targeting specific
substrates, such as talin1 (Franco et al., 2004) and vinculin
(Serrano and Devine, 2004), thereby affecting morphology of
platelets. There is evidence to suggest binding of talin1 to the β3
integrin results in activation of integrin αIIbβ3 and while
activation of αIIbβ3 also depends on the activity of calpain to
cleave talin1 (Petrich et al., 2007; Watanabe et al., 2008). Calpain-
2 cleaves 230 kDa talin1 into 190 kDa. Calpain activity was
significantly increased upon Yoda1 treatment, and Yoda1 led
to a modest but clear increase in cleaved activated talin (Aglialoro
et al., 2020), which is agreement with our finding that Yoda1
treatment led to a significant increase in talin cleavage
(Figure 6B).
We showed that exposure to shear resulted in no effect on the
protein expression of calpain-2 and vinculin in platelets
(Figure 6A). However, treatment with calpain-2 inhibitor
MDL28170 under shear rate of 4,000 s−1 significantly
suppressed cleavage of talin1 (Supplementary Figure S6),
suggesting that shear stimulates calpain-2 activity and then
cleavage of talin1. Yoda1 showed no direct effects on calpain-2
protein expression level, however, platelets treated with Yoda1
under shear rate of 4,000 s−1, enhanced talin1 cleavage and
increased its 190 kDa protein isoform, which is recruited to
form a complex with the GPIIbIIIa protein to induce
activation of platelets, with implications for thrombosis. These
results imply that shear-induced platelets aggregation is through
piezo1 channel-mediated calcium influx and calcium-dependent
activation of calpain-2 and subsequent talin1 cleavage. Treatment
with XST significantly attenuated the reduction in the 230 kDa
protein level or the increase in the 190 kDa protein level
(Figure 6B), suggesting XST inhibits shear induced activation
of calpain-2 and subsequent cleavage of talin1. Taken together,
our results suggest that XST inhibits shear-induced platelet
aggregation via Piezo1-mediated Ca2+ signaling and
subsequent calpain-2 activation and talin1 cleavage as
downstream signal pathways (Figure 7).
The results from this study implies that XST with clinical
concentrations might inhibit shear-induced platelet aggregation
via Piezo1 channel and calcium influx. As introduced above, XST
has been approved for its use in TCM to treat thrombosis. The
recommendation of clinical dosage of XST is 500 mg via
intravenous administration per day, which is approximately
equal to 0.10–0.15 g L−1 plasma concentration. According to the
human pharmacokinetics of XST study, these ginsenosides
exhibited increased maximum plasma total concentration (Cmax)
and area under the plasma concentration–time curve from 0 to
infinity (AUC0–∞) as the XST dose increased from 250 to 500 mg/
person. Intravenous repeatedly dosing of 500 mg XST for 15 days,
the Cmax of major ginsenosides is approximately 0.09–0.10 g L
−1
(Pintusophon et al., 2019). In our previous study, 0.15 g L−1of XST
showed significant effects on platelets activation and aggregation
(Han et al., 2019). In this study, we showed that treatment with
XST at 0.15 g L−1 remarkably inhibited shear-induced platelet
aggregation and treatment with XST at a high concentration of
0.6 g L−1 resulted in slightly greater inhibition (Figure 3). XST at
0.15 g L−1 also potently suppressed platelet aggregation induced by
elevated activation of the Piezo1 channel using Yoda1 in the
presence of shear stress (Figure 4). However, treatment with
XST even at the high concentration used in this study did not
change high shear induced vWF-mediated platelet adhesion and
rolling (Supplementary Figure S5). Taken together, these results
indicate that XST at a clinically relevant concentration
preferentially inhibits shear-induced platelet aggregation without
effect on interactions between platelet and vWF. We further
demonstrated using single Ca2+ imaging that treatment with
XST at 0.15 g L−1 was effective in inhibiting Piezo1-mediated
Ca2+ response in platelets induced by shear or combination of
shear and Yoda1, like treatment with GsMTx-4 (Figure 5).
Consistently, we showed using western blotting analysis that
treatment with XST significantly Yoda1-induced activation of
calpain-2 and cleavage of talin1 (Figure 6B). Collectively, our
results suggest that XST at a clinically relevant concentration
inhibits shear-induced platelet aggregation via Piezo1-mediated
Ca2+ signaling and downstream signal pathway (Figure 7),
providing novel insights into the molecular mechanisms
underpinning the therapeutic effects of XST.
In summary, our study shows that high shear induced platelet
aggregation might be via Piezo1-mediated Ca2+ signaling and
FIGURE 7 | Schematic summary of inhibition by XST of shear-induced
platelet aggregation. Exposure to shear activates the Piezo1 channel and
ensuing Piezo1-mediated Ca2+ influx. An increase in intracellular Ca2+ level in
turn stimulates calpain-2 and cleavage of talin1, leading to platelet
aggregation. Exposure to high shear rate also upregulates the expression of
Pizo1 channel (not depicted here). Treatment with XST at a clinically relevant
concentration inhibits shear-induced platelet aggregation via targeting the
Piezo1 channel.
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downstream signal pathway and XST at clinically relevant
concentrations inhibit shear-induced platelet aggregation by
preventing shear-induced activation of the Piezo1 channel.
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